At 10 weeks, should a suppressed TSH and mildly elevated free T4 trigger antithyroid treatment in a patient with severe vomiting? Not before deciding whether the pattern reflects hCG-mediated gestational transient thyrotoxicosis (GTT) or Graves disease. The distinction matters: antithyroid drugs are not indicated for GTT, while true overt Graves disease may need treatment during pregnancy.
Illustrative case: A 24-year-old at 10 weeks has lost 9% of her prepregnancy weight, cannot keep fluids down, is orthostatic, and has a potassium of 2.9 mmol/L. The immediate priority is clinically significant volume depletion and electrolyte disturbance—not assuming that a pulse of 110 proves thyroid-driven illness.
Stabilize the patient before interpreting the pulse
The history establishes severe vomiting and inability to eat or drink normally. Ask and document how symptoms affect usual daily activities; this patient-centered history is part of the contemporary clinical formulation of hyperemesis gravidarum (HG). Her orthostasis, weight loss, and hypokalemia show why she needs close treatment and monitoring.
Do not use the 4+ urine ketones as a severity score or as a required diagnostic criterion. Ketonuria does not reliably indicate dehydration or HG severity. In this case, the clinical examination and electrolyte abnormalities—not the urine dipstick—drive the immediate plan.
Treat volume depletion and hypokalemia with monitored fluid and electrolyte replacement. Dextrose-containing fluid is not routine replacement fluid for HG; if it is used, give thiamine first. Provide antiemetic therapy by a route she can tolerate. Reassess her heart rate after rehydration. Persistent tachycardia then deserves a fresh assessment; the initial value may be explained by hypovolemia.
Read the thyroid results in pregnancy context
Human chorionic gonadotropin (hCG) can weakly stimulate the thyroid-stimulating hormone receptor. Its effect is strongest in early pregnancy, when TSH may fall and free T4 may rise slightly. In a patient with severe early-pregnancy vomiting, this pattern can represent GTT rather than Graves disease.
The reported free T4 of 24 pmol/L is described as mildly elevated, but the vignette does not give the laboratory’s assay- and trimester-specific reference interval. Check that interval before labeling the result overt hyperthyroidism. A flagged result based only on a nonpregnant range may overstate what the test shows.
| Finding | More consistent with GTT | Raises concern for Graves disease |
|---|---|---|
| Timing and course | Starts with early-pregnancy vomiting; improves as the hCG-driven state and vomiting settle | Thyroid symptoms predate pregnancy or biochemical hyperthyroidism persists beyond the early-pregnancy pattern |
| History and examination | No clear thyroid history or Graves-specific findings after targeted assessment | Thyroid eye disease, known autoimmune disease, or a relevant personal or family history |
| Testing | Mild early-pregnancy changes that resolve on follow-up | Positive TRAb/TSI, or persistent hormone elevation that does not fit the clinical course |
No single clinical feature settles the diagnosis. The vignette does not describe a goiter; if examination confirms its absence, that fits the GTT pattern, but absence of a goiter does not rule out Graves disease. Ask about symptoms before pregnancy and autoimmune history; examine the thyroid and eyes. Her orthostatic tachycardia should not be counted as a Graves-specific symptom until volume depletion has been addressed.
Choose testing that can change the plan
If history, examination, and timing make hCG-mediated GTT likely and there are no other signs of Graves disease, the 2026 American Thyroid Association guideline says it is reasonable to repeat TSH and free T4 in 2–4 weeks before testing for thyroid receptor antibodies. If the picture is unclear, free T4 remains elevated using the appropriate pregnancy interval, or Graves features emerge, check TRAb or TSI. A T3 measurement may help distinguish causes in selected uncertain cases, but should not be used to monitor treatment.
If pregnancy number and ultrasound findings have not already been established, obstetric ultrasound can assess viability, dating, multiple gestation, and possible trophoblastic disease. These are relevant causes of high hCG; a low TSH alone does not diagnose them. Thyroid ultrasound is not a useful test for distinguishing GTT from Graves disease.
For likely GTT, treat the vomiting, dehydration, and electrolyte abnormalities; antithyroid drugs are not indicated for the transient thyroid pattern. If findings support overt Graves disease, treat the underlying hyperthyroidism—often with pregnancy-appropriate antithyroid therapy—using pregnancy-specific management and appropriate specialist input.
Avoid these reasoning traps
- Treating the number instead of the cause: A low TSH in the first trimester is not, by itself, a diagnosis of Graves disease.
- Calling every fast pulse thyrotoxicosis: Reassess after fluid replacement, especially when orthostasis and poor intake are present.
- Using one absent sign as an exclusion test: No goiter is reassuring context, not proof against Graves disease.
- Letting ketones stand in for clinical assessment: Intake, daily function, vital signs, weight history, and electrolyte or renal abnormalities matter more.
Practical takeaways
- In severe early-pregnancy vomiting, distinguish GTT from Graves before considering antithyroid therapy.
- Interpret free T4 using the relevant assay- and pregnancy-specific range; ask about pre-pregnancy symptoms and examine for Graves features.
- In a clear hCG-mediated pattern, repeat thyroid tests in 2–4 weeks; use TRAb/TSI when the diagnosis is uncertain or Graves is suspected.
- Stabilize the patient’s volume and potassium first. Do not mistake ketonuria for a severity measure or dehydration test.
